Chen, Allen Y.
Wolchok, Jedd D. http://orcid.org/0000-0001-6718-2222
Bass, Anne R. http://orcid.org/0000-0002-3225-8351
Article History
Accepted: 3 February 2021
First Online: 8 March 2021
Competing interests
: J.D.W. is a consultant for Adaptive Biotech, Amgen, Apricity, Arsenal, Ascentage Pharma, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, F Star, Imvaq, Kyowa Hakko Kirin, Merck, Neon Therapeutics, Psioxus, Recepta, Sellas, Serametrix, Surface Oncology, Syndax and Syntalogic, Takara Bio, Trieza and Truvax; receives research support from AstraZeneca, Bristol Myers Squibb and Sephora; and has equity in Adaptive Biotechnologies, Apricity, Arsenal, BeiGene, Imvaq, Linnaeus, Tizona Pharmaceuticals. The other authors declare no competing interests.